CLINICAL RIGOR | 1 The digital health industry has a credibility problem. In recent years, funding for digital health companies has grown from $4.8B in 2015 to $29.1B by year end 2021 as the market has increasingly recognized the potential impact digital care can have on outcomes. 1 But the frenzy driving this funding has also given rise to an influx of products that are not clinical grade, leaving patients and business buyers questioning whether or not they can trust the promises they hear from vendors. At Omada, it is our mission to do right by our members and customers, so we base our programs on clinically validated protocols and seek quality recognition from national accreditors. We believe that rigorous clinical research and scientific evidence should be at the

Join for free to read